About this Journal Submit a Manuscript Table of Contents
Journal of Signal Transduction
Volume 2012 (2012), Article ID 358476, 13 pages
http://dx.doi.org/10.1155/2012/358476
Review Article

The Role of Phosphoinositide 3-Kinase Signaling in Intestinal Inflammation

1Mucosal Immunology Laboratory, Department of Pediatrics, 114 16th Street, Massachusetts General Hospital for Children, Charlestown MA 02129, USA
2Neurochemistry Laboratory, Department of Psychiatry, 149 13th Street, Massachusetts General Hospital, Charlestown MA 02129, USA

Received 23 July 2011; Accepted 29 November 2011

Academic Editor: Axel Kallies

Copyright © 2012 Catherine M. Cahill et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Toker and L. C. Cantley, “Signalling through the lipid products of phosphoinositide-3-OH kinase,” Nature, vol. 387, no. 6634, pp. 673–676, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Vanhaesebroeck, S. J. Leevers, K. Ahmadi et al., “Synthesis and function of 3-phosphorylated inositol lipids,” Annual Review of Biochemistry, vol. 70, pp. 535–602, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Cantrell, “Phosphoinositide 3-kinase signalling pathways,” Journal of Cell Science, vol. 114, no. 8, pp. 1439–1445, 2001. View at Scopus
  4. J. Y. Lee, Y. H. Chiu, J. Asara, and L. C. Cantley, “Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85α Src homology-2 domains,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 34, pp. 14157–14162, 2011. View at Publisher · View at Google Scholar
  5. F. M. Foster, C. J. Traer, S. M. Abraham, and M. J. Fry, “The phosphoinositide (PI) 3-kinase family,” Journal of Cell Science, vol. 116, no. 15, pp. 3037–3040, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Fukao and S. Koyasu, “PI3K and negative regulation of TLR signaling,” Trends in Immunology, vol. 24, no. 7, pp. 358–363, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Fukao, M. Tanabe, Y. Terauchi et al., “P13K-mediated negative feedback regulation of IL-12 production in DCs,” Nature Immunology, vol. 3, no. 9, pp. 875–881, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Schmid, C. Avraamides, H. Dippold et al., “Receptor tyrosine kinases and TLR/IL1Rs Unexpectedly activate myeloid cell PI3Kγ, A single convergent point promoting tumor inflammation and progression,” Cancer Cell, vol. 19, no. 6, pp. 715–727, 2011. View at Publisher · View at Google Scholar
  9. P. Voigt, M. B. Dorner, and M. Schaefer, “Characterization of p87PIKAP, a novel regulatory subunit of phosphoinositide 3-kinase γ that is highly expressed in heart and interacts with PDE3B,” Journal of Biological Chemistry, vol. 281, no. 15, pp. 9977–9986, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Kagan and R. Medzhitov, “Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling,” Cell, vol. 125, no. 5, pp. 943–955, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. Engelman, J. Luo, and L. C. Cantley, “The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism,” Nature Reviews Genetics, vol. 7, no. 8, pp. 606–619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. J. Harris, J. G. Foster, and S. G. Ward, “PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategies,” Current Opinion in Investigational Drugs, vol. 10, no. 11, pp. 1151–1162, 2009. View at Scopus
  13. D. T. Patton, O. A. Garden, W. P. Pearce et al., “Cutting edge: the phosphoinositide 3-kinase p110δ is critical for the function of CD4+CD25+Foxp3+ regulatory T cells,” Journal of Immunology, vol. 177, no. 10, pp. 6598–6602, 2006. View at Scopus
  14. H. Ji, F. Rintelen, C. Waltzinger et al., “Inactivation of PI3Kγ and PI3Kδ distorts T-cell development and causes multiple organ inflammation,” Blood, vol. 110, no. 8, pp. 2940–2947, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Li, S. Jiang, and R. I. Tapping, “Toll-like receptor signaling in cell proliferation and survival,” Cytokine, vol. 49, no. 1, pp. 1–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Akira, “Toll-like receptor signaling,” Journal of Biological Chemistry, vol. 278, no. 40, pp. 38105–38108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Neumann, S. Lienenklaus, O. Rosati, and M. U. Martin, “IL-1β-induced phosphorylation of PKB/Akt depends on the presence of IRAK-1,” European Journal of Immunology, vol. 32, no. 12, pp. 3689–3698, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. C. C. Kuo, W. T. Lin, C. M. Liang, and S. M. Liang, “Class I and III phosphatidylinositol 3′-kinase play distinct roles in TLR signaling pathway,” Journal of Immunology, vol. 176, no. 10, pp. 5943–5949, 2006. View at Scopus
  19. S. M. Ivison, M. A. Khan, N. R. Graham et al., “A phosphorylation site in the Toll-like receptor 5 TIR domain is required for inflammatory signalling in response to flagellin,” Biochemical and Biophysical Research Communications, vol. 352, no. 4, pp. 936–941, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Li, J. C. Tupper, D. D. Bannerman, R. K. Winn, C. J. Rhodes, and J. M. Harlan, “Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-κB in endothelial cells,” Infection and Immunity, vol. 71, no. 8, pp. 4414–4420, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kamanaka, S. T. Kim, Y. Y. Wan et al., “Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse,” Immunity, vol. 25, no. 6, pp. 941–952, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. C. M. Cahill and J. T. Rogers, “Interleukin (IL) 1β induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IκB kinase α pathway targeting activator protein-1,” Journal of Biological Chemistry, vol. 283, no. 38, pp. 25900–25912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Santos-Sierra, S. D. Deshmukh, J. Kalnitski et al., “Mal connects TLR2 to PI3Kinase activation and phagocyte polarization,” EMBO Journal, vol. 28, no. 14, pp. 2018–2027, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Boch, Y. Yoshida, Y. Koyama et al., “Characterization of a cascade of protein interactions initiated at the IL-1 receptor,” Biochemical and Biophysical Research Communications, vol. 303, no. 2, pp. 525–531, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Marmiroli, A. Bavelloni, I. Faenza et al., “Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I,” FEBS Letters, vol. 438, no. 1-2, pp. 49–54, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Sizemore, S. Leung, and G. R. Stark, “Activation of phosphatidylinositol 3-kinase in response to interleukin- 1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit,” Molecular and Cellular Biology, vol. 19, no. 7, pp. 4798–4805, 1999. View at Scopus
  27. S. A. G. Reddy, Y. F. Lin, H. J. Huang, A. K. Samanta, and W. S. L. Liao, “The IL-1 receptor accessory protein is essential for PI 3-kinase recruitment and activation,” Biochemical and Biophysical Research Communications, vol. 316, no. 4, pp. 1022–1028, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Radons, S. Gabler, H. Wesche, C. Korherr, R. Hofmeister, and W. Falk, “Identification of essential regions in the cytoplasmic tail of interleukin-1 receptor accessory protein critical for interleukin-1 signaling,” Journal of Biological Chemistry, vol. 277, no. 19, pp. 16456–16463, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. S. A. G. Reddy, J. H. Huang, and W. S. Liao, “Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFκB and AP- 1 activation,” Journal of Biological Chemistry, vol. 272, no. 46, pp. 29167–29173, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Guo and S. Wu, “IRAK-2 and PI 3-kinase synergistically activate NF-κB and AP-1,” Inflammation, vol. 24, no. 4, pp. 305–316, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Z. Wang, N. Wara-Aswapati, J. A. Boch et al., “TRAF6 activation of PI 3-kinase-dependent cytoskeletal changes is cooperative with Ras and is mediated by an interaction with cytoplasmic Src,” Journal of Cell Science, vol. 119, no. 8, pp. 1579–1591, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. C. Ng, M. A. Kamm, A. J. Stagg, and S. C. Knight, “Intestinal dendritic cells: their role in bacterial recognition, lymphocyte homing, and intestinal inflammation,” Inflammatory Bowel Diseases, vol. 16, no. 10, pp. 1787–1807, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. S. C. Ng, S. Plamondon, M. A. Kamm et al., “Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis,” Inflammatory Bowel Diseases, vol. 16, no. 8, pp. 1286–1298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. E. Qualls, H. Tuna, A. M. Kaplan, and D. A. Cohen, “Suppression of experimental colitis in mice by CD11c+ dendritic cells,” Inflammatory Bowel Diseases, vol. 15, no. 2, pp. 236–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Krishnamoorthy, T. B. Oriss, M. Paglia et al., “Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma,” Nature Medicine, vol. 14, no. 5, pp. 565–573, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Rimoldi, M. Chieppa, V. Salucci et al., “Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells,” Nature Immunology, vol. 6, no. 5, pp. 507–514, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. P. D. Smith, L. E. Smythies, R. Shen, T. Greenwell-Wild, M. Gliozzi, and S. M. Wahl, “Intestinal macrophages and response to microbial encroachment,” Mucosal Immunology, vol. 4, no. 1, pp. 31–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Guha and N. Mackman, “The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells,” Journal of Biological Chemistry, vol. 277, no. 35, pp. 32124–32132, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Tsukamoto, K. Hazeki, M. Hoshi et al., “Critical roles of the p110β subtype of phosphoinositide 3-kinase in lipopolysaccharide-induced Akt activation and negative regulation of nitrite production in RAW 264.7 cells,” Journal of Immunology, vol. 180, no. 4, pp. 2054–2061, 2008. View at Scopus
  40. M. Martin, K. Rehani, R. S. Jope, and S. M. Michalek, “Toll-like receptor—mediated cytokine production is differentially regulated by glycogen synthase kinase 3,” Nature Immunology, vol. 6, no. 8, pp. 777–784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Chaurasia, J. Mauer, L. Koch, J. Goldau, A. S. Kock, and J. C. Brüning, “Phosphoinositide-dependent kinase 1 provides negative feedback inhibition to toll-like receptor-mediated NF-κB activation in macrophages,” Molecular and Cellular Biology, vol. 30, no. 17, pp. 4354–4366, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Günzl, K. Bauer, E. Hainzl et al., “Anti-inflammatory properties of the PI3K pathway are mediated by IL-10/DUSP regulation,” Journal of Leukocyte Biology, vol. 88, no. 6, pp. 1259–1269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Zhou, C. A. Collins, P. Wu, and E. J. Brown, “Protein tyrosine phosphatase SHP-1 positively regulates TLR-induced IL-12p40 production in macrophages through inhibition of phosphatidylinositol 3-kinase,” Journal of Leukocyte Biology, vol. 87, no. 5, pp. 845–855, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Ruckdeschel, G. Pfaffinger, R. Haase et al., “Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-β, but not MyD88, in bacteria-infected murine macrophages,” Journal of Immunology, vol. 173, no. 5, pp. 3320–3328, 2004. View at Scopus
  45. F. Autschbach, G. Schumann, L. Qiao, H. Merz, R. Wallich, and S. C. Meuer, “Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease,” Virchows Archiv, vol. 426, no. 1, pp. 51–60, 1995. View at Scopus
  46. J. C. Hoffmann, K. Peters, N. N. Pawlowski et al., “In vivo proliferation of rat lamina propria T lymphocytes: general hyporesponsiveness but increased importance of the CD2 and CD28 pathways,” Immunological Investigations, vol. 38, no. 6, pp. 466–482, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Hunig, G. Tiefenthaler, K. H. Meyer zum Buschenfelde, and S. C. Meuer, “Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand,” Nature, vol. 326, no. 6110, pp. 298–301, 1987. View at Scopus
  48. J. Braunstein, L. Qiao, F. Autschbach, G. Schurmann, and S. Meuer, “T cells of the human intestinal lamina propria are high producers of interleukin 10,” Immunobiology, vol. 197, no. 2-4, p. 216, 1997. View at Scopus
  49. J. Braunstein, F. Autschbach, T. Giese et al., “Up-regulation of the phosphoinositide 3-kinase pathway in human lamina propria T lymphocytes,” Clinical and Experimental Immunology, vol. 151, no. 3, pp. 496–504, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. E. J. Meuillet, D. Mahadevan, M. Berggren, A. Coon, and G. Powis, “Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity,” Archives of Biochemistry and Biophysics, vol. 429, no. 2, pp. 123–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Sturm, J. Itoh, J. W. Jacobberger, and C. Fiocchi, “p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling,” Journal of Clinical Investigation, vol. 109, no. 11, pp. 1481–1492, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Brennan, J. W. Babbage, B. M. T. Burgering, B. Groner, K. Reif, and D. A. Cantrell, “Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F,” Immunity, vol. 7, no. 5, pp. 679–689, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Hofmann, N. Dunger, J. Schölmerich, W. Falk, and F. Obermeier, “Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation,” Inflammatory Bowel Diseases, vol. 16, no. 11, pp. 1850–1858, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. A. E. Gelman, D. F. LaRosa, J. Zhang et al., “The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation,” Immunity, vol. 25, no. 5, pp. 783–793, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Panja, S. Goldberg, L. Eckmann, P. Krishen, and L. Mayer, “The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells,” Journal of Immunology, vol. 161, no. 7, pp. 3675–3684, 1998. View at Scopus
  56. G. W. Varilek, G. A. Neil, and W. P. Bishop, “Caco-2 cells express type I interleukin-1 receptors: ligand binding enhances proliferation,” American Journal of Physiology, vol. 267, no. 6, pp. G1101–G1107, 1994. View at Scopus
  57. L. S. Miller, E. M. Pietras, L. H. Uricchio et al., “Inflammasome-mediated production of IL-1β is required for neutrophil recruitment against Staphylococcus aureus in vivo,” Journal of Immunology, vol. 179, no. 10, pp. 6933–6942, 2007. View at Scopus
  58. B. Raupach, S. K. Peuschel, D. M. Monack, and A. Zychlinsky, “Caspase-1-mediated activation of interleukin-1β (IL-1β) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar typhimurium infection,” Infection and Immunity, vol. 74, no. 8, pp. 4922–4926, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. P. J. Sansonetti, A. Phalipon, J. Arondel et al., “Caspase-1 activation of IL-1β and IL-18 are essential for Shigella flexneri-induced inflammation,” Immunity, vol. 12, no. 5, pp. 581–590, 2000. View at Scopus
  60. S. L. Lebeis, K. R. Powell, D. Merlin, M. A. Sherman, and D. Kalman, “Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen citrobacter rodentium,” Infection and Immunity, vol. 77, no. 2, pp. 604–614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. M. T. Abreu, E. T. Arnold, J. Y. C. Chow, and K. E. Barrett, “Phosphatidylinositol 3-kinase-dependent pathways oppose fas-induced apoptosis and limit chloride secretion in human intestinal epithelial cells: implications for inflammatory diarrheal states,” Journal of Biological Chemistry, vol. 276, no. 50, pp. 47563–47574, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. E. P. Molmenti, T. Ziambaras, and D. H. Perlmutter, “Evidence for an acute phase response in human intestinal epithelial cells,” Journal of Biological Chemistry, vol. 268, no. 19, pp. 14116–14124, 1993. View at Scopus
  63. M. Kopf, H. Baumann, G. Freer et al., “Impaired immune and acute-phase responses in interleukin-6-deficient mice,” Nature, vol. 368, no. 6469, pp. 339–342, 1994. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov, “Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis,” Cell, vol. 118, no. 2, pp. 229–241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. N. N. Nanthakumar, R. D. Fusunyan, I. Sanderson, and W. A. Walker, “Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 11, pp. 6043–6048, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. L. Snoeks, C. R. Weber, K. Wasland et al., “Tumor suppressor FOXO3 participates in the regulation of intestinal inflammation,” Laboratory Investigation, vol. 89, no. 9, pp. 1053–1062, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Snoeks, C. R. Weber, J. R. Turner, M. Bhattacharyya, K. Wasland, and S. D. Savkovic, “Tumor suppressor Foxo3a is involved in the regulation of lipopolysaccharide-induced interleukin-8 in intestinal HT-29 cells,” Infection and Immunity, vol. 76, no. 10, pp. 4677–4685, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. C. M. Cahill, G. Tzivion, N. Nasrin et al., “Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways,” Journal of Biological Chemistry, vol. 276, no. 16, pp. 13402–13410, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. N. Nasrin, S. Ogg, C. M. Cahill et al., “DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 19, pp. 10412–10417, 2000. View at Scopus
  70. S. H. Rhee, “Basic and translational understandings of microbial recognition by Toll-like receptors in the intestine,” Journal of Neurogastroenterology and Motility, vol. 17, no. 1, pp. 28–34, 2011. View at Publisher · View at Google Scholar
  71. Y. Yu, S. Nagai, H. Wu, A. S. Neish, S. Koyasu, and A. T. Gewirtz, “TLR5-mediated phosphoinositide 3-kinase activation negatively regulates flagellin-induced proinflammatory gene expression,” Journal of Immunology, vol. 176, no. 10, pp. 6194–6201, 2006. View at Scopus
  72. F. C. Huang, Q. Li, and B. J. Cherayil, “A phosphatidyl-inositol-3-kinase-dependent anti-inflammatory pathway activated by Salmonella in epithelial cells,” FEMS Microbiology Letters, vol. 243, no. 1, pp. 265–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. H. R. Sang, H. Kim, M. P. Moyer, and C. Pothoulakis, “Role of MyD88 in phosphatidylinositol 3-kinase activation by flagellin/toll-like receptor 5 engagement in colonic epithelial cells,” Journal of Biological Chemistry, vol. 281, no. 27, pp. 18560–18568, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Zeng, H. Wu, V. Sloane et al., “Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 290, no. 1, pp. G96–G108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. X. D. Peng, X. H. Wu, L. J. Chen et al., “Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 332, no. 1, pp. 46–56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. W. A. van Dop, S. Marengo, A. A. te Velde et al., “The absence of functional PI3Kγ prevents leukocyte recruitment and ameliorates DSS-induced colitis in mice,” Immunology Letters, vol. 131, no. 1, pp. 33–39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. A. González-García, J. Sánchez-Ruiz, J. M. Flores, and A. C. Carrera, “Phosphatidylinositol 3-kinase γ inhibition ameliorates inflammation and tumor growth in a model of colitis-associated cancer,” Gastroenterology, vol. 138, no. 4, pp. 1374–1383, 2010. View at Publisher · View at Google Scholar
  78. N. M. Dagia, G. Agarwal, D. V. Kamath et al., “A preferential p110α/γ PI3K inhibitor attenuates experimental inflammation by suppressing the production of proinflammatory mediators in a NF-κB-dependent manner,” American Journal of Physiology—Cell Physiology, vol. 298, no. 4, pp. C929–C941, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. X. L. Huang, W. Q. Yi, M. Zhang, Q. Ouyang, and H. T. Gan, “Expression of phosphatidylinositol 3-kinase and effects of wortmannin on the expression of tumor necrosis factor-alpha in ulcerative colitis,” Zhonghua Yi Xue Za Zhi, vol. 87, no. 6, pp. 379–382, 2007. View at Scopus
  80. R. C. Dutra, M. Cola, D. F.P. Leite et al., “Inhibitor of PI3Kγ ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3 + regulatory T cells,” British Journal of Pharmacology, vol. 163, no. 2, pp. 358–374, 2011. View at Publisher · View at Google Scholar
  81. M. Iizuka and S. Konno, “Wound healing of intestinal epithelial cells,” World Journal of Gastroenterology, vol. 17, no. 17, pp. 2161–2171, 2011. View at Publisher · View at Google Scholar
  82. S. A. Weaver and S. G. Ward, “Phosphoinositide 3-kinases in the gut: a link between inflammation and cancer?” Trends in Molecular Medicine, vol. 7, no. 10, pp. 455–462, 2001. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Attoub, O. De Wever, E. Bruyneel, M. Mareel, and C. Gespach, “The transforming functions of PI3-kinase-γ are linked to disruption of intercellular adhesion and promotion of cancer cell invasion,” Annals of the New York Academy of Sciences, vol. 1138, pp. 204–213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Ebi, R. B. Corcoran, A. Singh et al., “Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers,” Journal of Clinical Investigation, vol. 121, no. 11, pp. 4311–4321, 2011. View at Publisher · View at Google Scholar
  85. N. T. Ihle, G. Powis, and S. Kopetz, “PI-3-Kinase inhibitors in colorectal cancer,” Current Cancer Drug Targets, vol. 11, no. 2, pp. 190–198, 2011. View at Publisher · View at Google Scholar
  86. N. T. Ihle and G. Powis, “Inhibitors of phosphatidylinositol-3-kinase in cancer therapy,” Molecular Aspects of Medicine, vol. 31, no. 2, pp. 135–144, 2010. View at Publisher · View at Google Scholar · View at Scopus